Cardioembolic Stroke: Clinical Features, Specific Cardiac Disorders and Prognosis by Arboix, Adrià & Alió, Josefina
150  Current Cardiology Reviews, 2010, 6, 150-161   
    1573-403X/10 $55.00+.00  © 2010 Bentham Science Publishers Ltd. 
Cardioembolic Stroke: Clinical Features, Specific Cardiac Disorders and 
Prognosis 
Adrià Arboix
a,b,* and Josefina Alió
c 
aCerebrovascular Division, Department of Neurology, Hospital Universitari del Sagrat Cor, Universitat de Barcelona, 
Barcelona, Spain; 
bCIBER de Enfermedades Respiratórias
  (CB06/06). Instituto Carlos III, Madrid; 
cDepartment of 
Cardiology, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain 
Abstract: This article provides the reader with an overview and up-date of clinical features, specific cardiac disorders and 
prognosis of cardioembolic stroke. Cardioembolic stroke accounts for 14-30% of ischemic strokes and, in general, is a 
severe condition; patients with cardioembolic infarction are prone to early and long-term stroke recurrence, although 
recurrences may be preventable by appropriate treatment during the acute phase and strict control at follow-up. Certain 
clinical features are suggestive of cardioembolic infarction, including sudden onset to maximal deficit, decreased level of 
consciousness at onset, Wernicke’s aphasia or global aphasia without hemiparesis, a Valsalva manoeuvre at the time of 
stroke onset, and co-occurrence of cerebral and systemic emboli. Lacunar clinical presentations, a lacunar infarct and 
especially multiple lacunar infarcts, make cardioembolic origin unlikely. The more common high risk cardioembolic 
conditions are atrial fibrillation, recent myocardial infarction, mechanical prosthetic valve, dilated myocardiopathy, and 
mitral rheumatic stenosis. Transthoracic and transesophageal echocardiogram can disclose structural heart diseases. 
Paroxysmal atrial dysrhyhtmia can be detected by Holter monitoring. In-hospital mortality in cardioembolic stroke 
(27.3%, in our series) is the highest as compared with other subtypes of cerebral infarction. In our experience, in-hospital 
mortality in patients with early embolic recurrence (within the first 7 days) was 77%. Patients with alcohol abuse, 
hypertension, valvular heart disease, nausea and vomiting, and previous cerebral infarction are at increased risk of early 
recurrent systemic embolization. Secondary prevention with anticoagulants should be started immediately if possible in 
patients at high risk for recurrent cardioembolic stroke in which contraindications, such as falls, poor compliance, 
uncontrolled epilepsy or gastrointestinal bleeding are absent. 
Keywords: Cardioembolic stroke, recurrent embolization, atrial fibrillation, cardiac source of emboli, outcome. 
INTRODUCTION 
Stroke is the leading cause of disability and the second most 
common cause of death worldwide [1,2]. Accurate definition 
of the mechanism of stroke is crucial as this will guide the 
most effective care and therapy. Cardioembolic stroke 
accounts for 14-30% of all cerebral infarctions [3-7]. In most 
cases, recurrence of cardioembolism can be prevented by 
oral anticoagulants. Therefore, for a patient with a cerebral 
infarct, early confirmation of a diagnosis of cardioembolic 
infarction is extremely important in order to initiate antico-
agulation therapy for an adequate secondary prevention [8-
12]. 
  In the Sagrat Cor Hospital of Barcelona Stroke Registry, 
the frequency of cardioembolic stroke is 18% [13], a similar 
percentage than that in the studies of Bougousslavsky et al. 
[14] (16%) and Timsit et al. [15] (19.4%), higher than that 
reported by Vázquez et al. [16] (14%) and de Al-Rajed et al. 
[17] (14%), but lower than the percentages of Rothrock et al. 
[18] (22%) and Norrving and Löwenhielm [19] (30.6%). 
However, the incidence of cardioembolic stroke increases 
with age [13]. In the subgroup of patients younger than 65  
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years of age, cardioembolic stroke occurred in 14.6% of 
cases but in very old patients (age  85 years) cardioembolic 
stroke reached 36% of cases (Table 1). 
  Embolism from the heart to the brain results from one of 
three mechanisms: blood stasis and thrombus formation in an 
enlarged (or affected by another structure alteration) left 
cardiac chamber (e.g., left ventricular aneurysm); release of 
material from an abnormal valvular surface (e.g., calcific 
degeneration); and abnormal passage from the venous to the 
arterial circulation (paradoxical embolism) [2]. Cardiac 
emboli can be of any size, but those of arising from the 
cardiac chambers are often large and hence especially likely 
to cause severe stroke, disability and death. Cardioembolic 
infarction is generally the most severe ischemic stroke 
subtype, with a low frequency of symptom-free at hospital 
discharge, a high risk of early and late embolic recurrences, 
and a high mortality [3,6] (Fig. 1).  
  There is no gold standard for making the diagnosis of 
cardioembolic stroke. The presence of a potential major 
cardiac source of embolism in the absence of significant 
arterial disease remains the mainstay of clinical diagnosis. 
When cardiac and arterial disease coexist (such as atrial 
fibrillation and ipsilateral carotid atheroma), determining the 
etiology of the ischemic stroke becomes more difficult. 
However, in many patients, history, physical examination, 
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on neuroimaging studies) are sufficient to easily make the 
diagnosis of most presumed cardiac emboligenic condition 
(e.g., atrial fibrillation, recent myocardial infarction, heart 
failure, prior rheumatic disease, splinter hemorrhages). An 
important exception is paroxysmal atrial fibrillation, which 
can be detected by 24-48 hour Holter monitoring imme-
diately after stroke. Transthoracic echocardiogram can 
disclose structural cardiopathies (dilated cardiomyopathies, 
mitral stenosis and other structural ventricular diseases and 
intraventricular thrombus, vegetations or tumors) and 
enables measurement of the left atrial size and left ventri-
cular systolic function [1,2]. Transesophageal echocardio-
gram is able to study the aortic arch and ascending aorta, left 
atrium and left atrial appendages, intra-arterial septum, 
pulmonary veins and valve vegetations [1,3]. Transesopha-
geal echocardiography is more likely to be helpful in young 
patients with stroke, stroke of unknown cause and in patients 
with non-lacunar stroke. Cardiac magnetic resonance 
imaging (MRI) and nuclear cardiology studies (assessment 
of myocardial perfusion and analysis of ventricular function) 
may be useful in selected patients. 
CLINICAL FEATURES 
  Clinical features that support the diagnosis of 
cardioembolic stroke includes sudden onset to maximal 
deficit (< 5 min), which is present in 47-74% of cases and 
decreased level of consciousness at onset in 19-31% of cases 
[20,21]. In the study of Timsit et al. [22], altered cons-
ciousness was a predictive factor of cardioembolic 
infarction, with an odds ratio (OR) of 3.2 as compared with 
atherothrombotic infarction. Sudden onset of neurological 
deficit occurs in 79.7% of cases of cardioembolic stroke and 
in 38% of lacunar infarcts and in 46% of thrombotic 
infarctions (P < 0.01). 
  In 4.7-12% of cases, cardioembolic infarctions show a 
rapid regression of symptoms (the spectacular shrinking 
deficit syndrome) [23-26]. The recognition of this syndrome 
Table 1.  Distribution of Cerebral Infarctions According to Age in the Sagrat Cor Hospital of Barcelona Stroke Registry 
Years of Age  Subtype of Cerebral 
Infarction 
(n = 1840) 
< 65 
(n= 314) 
65–74  
(n=501) 
75–84  
(n=722) 
 85  
(n=303) 
Cardioembolic  46 (14.6)  100 (20)  213 (29.5)  109 (36) 
Atherothrombotic  66 (21.0)  159 (31.7)  233 (32.3)  95 (31.4) 
Lacunar  93 (29.6)  159 (31.7)  173 (24)  59 (19.5) 
Unknown cause  61 (19.4)  69 (13.8)  81 (11.2)  37 (12.2) 
Unusual cause  48 (15.3)  14 (2.8)  22 (3.0)  3 (1) 
Percentages in parenthesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Histopathological specimen showing a hemorrhagic cerebral infarction of a cardioembolic origin with signs of ventricular 
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is important for a clinical suspicion of the cardioembolic 
origin of the cerebral infarction [26]. This dramatic impro-
vement of an initially severe neurological deficit may be due 
to distal migration of the embolus followed by recanalization 
of the occluded vessel [27-29]. 
  Wernicke’s aphasia or global aphasia without hemi-
paresis are other common secondary symptoms of cardioem-
bolism [27,28]. In the posterior circulation, cardioembolism 
can produce Wallenberg’s syndrome, cerebellar infarcts, top-
of-the basilar syndrome, multilevel infarcts, or posterior-
cerebral-artery infarcts. Visual-field abnormalities, neglect, 
and aphasia are also more common in cardioembolic than in 
non-cardioembolic stroke.  
  A classic cardioembolic presentation include onset of 
symptoms after a Valsalva-provoking activity (coughing, 
bending, etc.) suggesting paradoxical embolism facilitated 
by a transient rise in right atrial pressure and the co-
occurrence of cerebral and systemic emboli
 [29].  
  On the other hand, other clinical symptoms classically 
associated with cardioembolic infarction, such as headache, 
seizures at onset [23] and onset during activity are not 
specific for cardioembolic stroke [4,27]. In addition, some 
signs or syndromes, such as lacunar clinical presentations 
(e.g., pure motor hemiparesis or ataxic hemiparesis), a 
lacunar infarct and particularly, multiple lacunar infarcts, 
make cardioembolic origin unlikely [30]. Cardiac embolism 
is a very rare cause of lacunar infarction (2.6-5% of cases) 
[31,32].
 
  Neuroimaging data that support cardioembolic stroke 
include simultaneous or sequential strokes in different 
arterial territories. Owing to their large size, cardiac emboli 
flow to the intracranial vessels in most cases and cause 
massive, superficial, single large striatocapsular or multiple 
infarcts in the middle cerebral artery. Therefore, cardio-
embolic infarctions predominate in the carotid and middle 
cerebral artery distribution territories [28,29,33].
  On the 
computed tomography (CT) scan, bihemispheric combined 
anterior and posterior circulation, or bilateral or multilevel 
posterior infarcts are suggestive of cardioembolism. MRI 
studies can increase the suspicion of cardio-embolism by 
demonstrating lesions not apparent on CT scans [1].  
  Hemorrhagic transformation of an ischemic infarct and 
early recanalization of an occluded intracranial vessel are 
suggestive of a cardiac origin of the stroke [1-3]. Hemorr-
hagic transformation occurs in up to 71% of cardioembolic 
strokes (Fig. 2). As many as 95% of hemorrhagic infarcts are 
caused by cardioembolism. There are two types of hemorr-
hagic transformation: petechial or multifocal, which is 
normally asymptomatic and secondary hematoma, which has 
mass effects and clinical deterioration [34]. Secondary 
hematomas are unusual and are found in 0.8% of cases in our 
stroke registry [13]. The traditional explanation for hemorr-
hagic transformation is that the infarct is caused by blockage 
of a large artery by the thrombus; this blockage then causes 
local vascular spasm. Release of this local spasm and 
fragmentation of the thrombus allow the thrombus to migrate 
distally, exposing ischemic tissues and damaged vessel walls 
and capillaries to reperfusion. Arterial dissection at the site 
of impact of the thrombus is an alternative explanation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Hemorrhagic cardioembolic infarction in a patient with a 
spectacular shrinking deficit syndrome visualized in the brain MRI 
study (spin-echo hyperintensity T1-weighted image).  
 
  Decreased alertness, total circulation infarcts, severe 
strokes (NIHSS >14), proximal middle cerebral artery 
occlusion, hypodensity in more than one third of the middle 
cerebral artery territory and delayed recanalization (> 6 
hours after stroke onset) together with absence of collateral 
flow predict hemorrhagic transformation in acute cardio-
embolic stroke [1,4]. 
SPECIFIC CARDIAC DISORDERS 
A number of cardiac conditions have been proposed as 
potential sources of embolism. The risk of embolism is 
heterogeneous. The more common high risk cardioembolic 
conditions are atrial fibrillation, recent myocardial infarction, 
mechanical prosthetic valve, dilated myocardiopathy, and 
mitral rheumatic stenosis. Other major sources of cardioem-
bolism include infective endocarditis, marantic endocarditis, 
and atrial myxoma. Minor sources of cardioembolism are 
patent foramen ovale, atrial septal aneurysm, atrial or 
ventricular septal defects, calcific aortic stenosis, and mitral 
annular calcification [5]. 
  Atrial fibrillation is the most important cause of cardio-
embolic stroke [20,21].
 Atrial fibrillation is the commonest 
sustained cardiac arrhythmia. Prevalence of atrial fibrillation 
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years of age, and both its incidence and prevalence are 
increasing. The disorder is associated with valvular heart 
disease, thyroid disorders, hypertension, and recent heavy 
drinking of alcohol. In Western populations, most causes of 
atrial fibrillation are unrelated to mitral valve disease. 
Instead, atrial fibrillation is now mainly secondary to 
ischemic or hypertensive heart disease. The attributable risk 
of stroke due to atrial fibrillation rises from 1.5% at the age 
of 50 to 24% at the age of 80. The incidence of stroke in 
people with non-valvular atrial fibrillation is estimated to be 
2 to 7 times higher than in people without atrial fibrillation 
and for those with valvular atrial fibrillation, the risk is 17 
times higher than that in age-matched controls. Chronic and 
recurrent atrial fibrillation appears to carry very similar 
stroke risk. Atrial fibrillation in the absence of organic heart 
disease or risk factors (lone atrial fibrillation) appears to 
carry significantly lower risk especially in younger patients 
(approximately 1.3% per year). Atrial fibrillation causes 
stroke because it leads to inadequate contraction of, and 
leads to stasis that is most marked in the left atrial appen-
dage. Stasis is associated with increased concentrations of 
fibrinogen, D-dimer, and von Willebrand factor, which are 
indicative of a prothrombotic state, which in turn predisposes 
to thrombus formation with consequent increased rate of 
cerebral embolization [1]. In these patients, left ventricular 
dysfunction and left atrial size were independent echocar-
diographic predictors of later thromboembolism. Other 
factors associated with a particular high embolic risk are 
spontaneous echo contrast, left atrial thrombus or aortic 
plaque detected by transesophageal echocardiogram. Heart 
failure, hypertension, age > 75 years, and diabetes mellitus 
increase the risk of stroke in a more moderate but additive 
fashion [3].  
  The bradycardia-tachycardia (sick sinus)  syndrome can 
be associated with cerebral embolic events. 
  Approximately 2.5% of patients with acute myocardial 
infarction experience a stroke within 2 to 4 weeks of the 
infarction, and 8% of men and 11% of women will have an 
ischemic stroke within the next 6 years. Factors that enhance 
the risk of stroke include severe left ventricular dysfunction 
with low cardiac output, left ventricular aneurysm (Fig. 3) or 
thrombus, and associated arrhythmias such as atrial 
fibrillation. Patients with an ejection fraction of less than 
28% had a relative risk of stroke of 1.86 compared with 
patients with an ejection fraction greater than 35%. The 
incidence of early embolism is high, possibly up to 22% in 
the presence of a mural thrombus and is most likely when 
the thrombus is mobile or protrudes into the ventricle [6].  
  The annual rate of stroke in patients with congestive 
heart failure is 2%. The risk of stroke correlates with the 
severity of left ventricular dysfunction. Coexistent disease 
has a cumulative effect, and the combination of recent 
congestive heart failure and atrial fibrillation places the 
patient at particular high risk for cardioembolic stroke [2]. 
  Rheumatic valvular heart disease (Fig. 4) and mechanical 
prosthetic valves are well recognized risk factors for stroke 
even in the absence of documented atrial fibrillation. The 
two most commonly cited rheumatic valve abnormalities are 
mitral stenosis and calcific aortic stenosis [2].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Transthoracic echocardiography shows a left ventricular 
aneurysm (VI) in a patient with history of acute myocardial infarc-
tion. 
 
 
 
 
 
 
 
 
 
 
Fig (4). Transthoracic echocardiography reveals a thrombus in the 
left atrium (T) in a patient with double rheumatic mitral valve 
lesion and atrial fibrillation. 
 
  Two types of endocarditis, infective and non-infective, 
can cause stroke. Non-infective endocarditis can complicate 
systemic cancer, lupus, and the anti-phospholipid syndrome. 
Infective endocarditis is complicated by stroke in about 10% 
of cases. Most stroke happens early (before or during the 
first 2 weeks of appropriate antimicrobial therapy). Emboli 
can be multiple especially in the case of infection of 
prosthetic valves and in infections due to aggressive agents, 
such as Staphylococcus aureus. Mycotic aneurysm is an 
uncommon (1-5%) complication of infective endocarditis. 
They may also enlarge and rupture, which is fatal in many 
cases (Fig. 5). 
  Myxomas account for more than half of primary cardiac 
tumors and thromboembolism is the most common presen-
ting symptom in patients with myxomas. Other primary 
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  Patent foramen ovale and aortic arch atheroma are 
emerging embolic sources that are extensively described in 
other chapters. 
  Mitral annular calcification has been cited as a possible 
source of cerebral embolism with a relative risk of stroke of 
2.1 in the Framingham Study independent of traditional risk 
factors for stroke [5]. In a recent study in patients with 
ischemic stroke of uncertain etiology, dense mitral annular 
calcification was an important marker of aortic arch 
atherosclerosis with high risk of embolism [35]. 
  Spontaneous echo contrast is an independent echocar-
diographic risk factor for left atrial thrombus and its appen-
dage and cardiac thromboembolic events.  
    Cardiological substrate and pathophysiological mecha-
nisms presumptively involved in cardioembolic stroke in the 
Sagrat Cor Hospital of Barcelona Stroke Registry [36] are 
shown in Table 2. Atrial dysrhythmia without structural 
cardiac disease was documented in 89 (22%) patients, with a 
mean (SD) age of 75 (4) years (range 6390 years). All these 
patients had normal electrocardiographic findings and 90% 
were asymptomatic. The cardiac condition associated with 
cardiogenic stroke was atrial fibrillation in 88 patients 
(chronic 67, paroxysmal 18, persistent 3) and atrial flutter in 
1. A previous diagnosis of atrial dysrhythmia had been 
established in the outpatient setting in 51% of patients but 
none of the patients received anticoagulation. 
  Structural cardiac disease with sustained sinus rhythm 
was diagnosed in 81 (20%) of patients. Left ventricular 
systolic dysfunction was documented in 59 patients (ische-
mic heart disease in 35 and dilated cardiomyopathy in 24) 
associated with intraventricular thrombosis in 13. Other less 
frequent cardiac disorders included mitral annular calcifi-
cation, cardiac tumors, aortic prosthetic valve, endocarditis, 
atrial septal aneurysm with patent foramen ovale, rheumatic 
mitral valve disease, mitral valve prolapse, calcified aortic 
stenosis with embolism during catheterization, and moderate 
mitral valve regurgitation. 
  In the remaining 232 (58%) patients, structural cardiac 
disorders were associated with atrial fibrillation in 230 cases 
and atrial flutter in 2. Hypertensive left ventricular 
hypertrophy was documented in 120 cases followed by 
rheumatic mitral valve disease in 49 cases and left ventri-
cular dysfunction in 32 cases (ischemic heart disease in 19 
and dilated cardiomyopathy in 13). Other less frequent 
cardiac disorders complicated with atrial fibrillation included 
mitral valve prolapse, mitral prosthesis, hypertrophic cardio-
myopathy, lipomatous hypertrophy of the atrial septum, 
severe mitral regurgitation, and atrial septal aneurysm with 
patent foramen ovale. 
  The frequency of the different cardiac disorders in the 
overall series of 402 patients with cardioembolic stroke is 
shown in Table 3. Atrial fibrillation was documented in 
79.1% of patients (in association with structural cardiac 
disease in 72% of cases) followed by hypertensive left 
ventricular hypertrophy in 29.8% of patients, left ventricular 
dysfunction in 22.6%, rheumatic mitral valve disease in 
12.4%, and mitral annular calcification in 9.9%. Mitral valve 
prolapse, atrial septal aneurysm with patent foramen ovale 
and degenerative heart valve disease were observed in only 
1% of the patients. In the group of 118 patients with 
hypertensive left ventricular hypertrophy associated with 
atrial fibrillation, anteroposterior diameter of the left atrium 
was significantly larger than in the group of 88 patients with 
lone atrial fibrillation (45 ± 3 mm vs. 41 ± 3 mm, P < 0.001). 
On the other hand, 80.6% of these patients were asympto-
matic, 50.5% had other vascular risk factor (cigarette 
smoking, diabetes mellitus, hyperlipidemia) besides hyper-
tensive disease, and although a previous diagnosis of atrial 
dysrhythmia had been established in the outpatient setting in 
43.7% of patients, none of the patients received anticoa-
gulation at the time of stroke onset. 
MORTALITY OF CARDIOEMBOLIC INFARCTIONS 
  Cardioembolic infarctions are the subtype of ischemic 
infarcts with the highest in-hospital mortality during the 
 
 
 
 
 
 
 
 
 
Fig. (5). Right lobar hemorrhage (A) secondary to rupture of a mycotic aneurysm in the course of an infective bacterial endocarditis; 
transthoracic echocardiography (B) shows an abscess in the posterolateral aortic root (a) between the aortic valve leaflets and the mitral 
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Table  2. Cardiac Disorders and Pathophysiological Mechanisms Presumptively Associated with Cardioembolic Stroke in 402 
Patients. Distribution by Cardiac Source Risk Groups. Sagrat Cor Hospital of Barcelona Stroke Registry 
Cardiac Source of Embolism  Total Patients 
Arrhythmia without structural heart disease  89 (22.1%)   
     Atrial fibrillation   88 
     Atrial flutter      1 
Isolated structural heart disease  81 (20.1%)   
     Ischaemic heart disease 
  35
 
          Acute myocardial infarction      3 (thrombus 2) 
          Left ventricular aneurysm      7 (thrombus 3) 
          Left ventricular ejection fraction < 40%    12 
Akinesia/dyskinesia  two segments    13 (thrombus 3) 
     Dilated cardiomyopathy    24 (thrombus 5) 
     Mitral annular calcification   14
* 
     Cardiac tumour      4 
     Aortic prosthetic valve      4 
     Endocarditis      2 
     Atrial septal aneurysm with patent foramen ovale      2 
     Rheumatic mitral valve disease      1 
     Mitral valve prolapse      1 
     Calcified aortic stenosis      1 
     Moderate mitral valve regurgitation      1 
Structural heart disease and atrial arrhythmia  232 (57.7%)   
     Atrial fibrillation   230 
     Atrial flutter       2 
     Hypertrophic hypertensive cardiac disease    120 
     Rheumatic mitral valve disease      49 (thrombus 7) 
     Ischaemic heart disease      19 
          Left ventricular aneurysm        3 (thrombus 1) 
          Left ventricular ejection fraction < 40%        9 
          Akinesia/dyskinesia  two segments        7 (thrombus 1) 
     Mitral annular calcification      26
† 
     Dilated cardiomyopathy      13 (thrombus 2) 
     Mitral valve prolapse       4 
     Mitral prosthetic valve       3 (thrombus 2) 
     Lipomatous hypertrophy of the atrial septum       2 
     Hypertrophic cardiomyopathy       2 
     Atrial septal aneurysm and patent foramen ovale       2 
     Severe mitral regurgitation       2 
*In 8 patients in association with a structural cardiac source of embolism (dilated cardiomyopathy, n=2; ischaemic heart disease with ventricular ejection fraction < 40%, n=2; acute 
myocardial infarction, n=1; left ventricular aneurysm, n =1; aortic prosthetic valve, n=1; mitral leaflet calcification with moderate regurgitation, n=1). 
†In 10 patients in association with a structural cardiac source of embolism (hypertensive left ventricular hypertrophy, n=8; mitral leaflet calcification with severe degenerative type 
regurgitation, n=2). 156    Current Cardiology Reviews, 2010, Vol. 6, No. 3  Arboix and Alió 
Table 3.  Frequency of the Different Cardiological Substrate in 402 Patients with Cardioembolic Stroke in the Sagrat Cor Hospital of 
Barcelona Stroke Registry 
Cardiac Source of Embolism  Total Patients 
Atrial fibrillation  318 (79.1%)   
     Lone atrial fibrillation      88 
     Associated with structural cardiac disease    230 
Hypertensive left ventricular hypertrophy  120 (29.8%)   
     Associated with atrial fibrillation   118 
     Associated with atrial flutter        2 
Left ventricular systolic dysfunction  91 (22.6%)   
     Sinus rhythm      59 
     Atrial fibrillation      32 
Rheumatic mitral valve disease  50 (12.4%)   
Mitral annular calcification  40 (9.9%)   
Mitral valve prolapse    5 (1.2%)   
Atrial septal aneurysm with patent foramen ovale    4 (1%)   
Degenerative heart valve disease    4 (1%)   
 
acute phase of stroke [37-39]. In our experience and in 
agreement with the clinical series of Caplan et al. [34], the 
in-hospital mortality rate of cardioembolic infarction was 
27.3% as compared with 0.8% for lacunar infarcts and 
21.7% for atherothrombotic stroke (P < 0.01). Cardioem-
bolic infarction is also associated with a lower rate of 
absence of functional limitation at discharge from the 
hospital, which may be related to the greater size of the 
lesion of cardioembolic stroke [15,22].  
  In a recent study carried out by our group in 231 patients 
with cardioembolic infarction with an in-hospital mortality 
rate of 27.3%, causes of death were as follows: a) non-
neurological in 54% (n = 34), including pneumonia in 9, 
heart disease in 7, pulmonary thromboembolism in 7, sepsis 
in 5, sudden death in 4, and other causes in 2; b) neurological 
in 39.5% (n = 25), including brain herniation in 17, recur-
rence of cerebral ischemia in 6, and cerebral hemorrhage in 
2; and of unknown cause in 6.5% (n = 4). 
  Early recurrent embolisms (within the first 7 days of 
stroke onset) were observed in 9 patients (3.9%) (peripheral 
embolisms in the extremities in 4, cerebral in 5). Only one 
patient was receiving therapeutic anticoagulation. 
  Mortality in patients with early embolic recurrence was 
77.7% (7 of 9 cases) as compared with 25% for the 
remaining patients (P < 0.001). In the 5 patients with 
recurrent cerebral embolisms, the mortality rate was 100%. 
Two of the four patients with peripheral embolism died 
(mortality rate 50%). 
  In the multivariate analysis, four clinical variables were 
significantly associated with in-hospital mortality: age, 
congestive heart failure, hemiparesis, and decreased level of 
consciousness. However, when early recurrent embolism 
was added to the logistic regression model, this variable was 
associated with the highest risk for death (OR = 33.5). 
  Early and late embolic recurrences are not exceptional in 
cardioembolic infarction [38,40-42]. Recurrences are more 
frequent during the first days of stroke [10]. In the study of 
Sacco et al. [43], in which recurrences within the first 30 
days were assessed, mortality was also significantly higher 
in the group of recurrences (20%) than in the group without 
recurrences (7.4%); survivors after stroke recurrence also 
showed a longer hospital stay. In the study of Yasaka et al. 
[44], mortality was also significantly higher in patients with 
recurrent embolism (19.6%) as compared with the remaining 
patients (8.8%). 
  Taking into account that in our series, only one patient 
with recurrent embolism was treated with therapeutic 
anticoagulation, we agree with Chamorro et al. [8] in the 
need of starting early prophylactic anticoagulation with 
sodium heparin in patients with cardioembolic infarction, 
with strict control of partial thromboplastin time (between 
1.5 and 2) in order to prevent iatrogenic bleeding due to 
excessive anticoagulation. 
EMBOLIC RECURRENCE IN CARDIOEMBOLIC 
INFARCTION 
  The risk of early stroke recurrence in cerebral infarctions 
in general ranges between 1% to 10% according to the 
different series [38,40-42]. Some studies have shown that 
recurrences within the first 3 months are more common in 
cardioembolic infarction than in atherothrombotic infarcts. 
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varies between 1% and 22%. In the Cerebral Embolism Task 
Force, for example, it was estimated that around 12% of 
patients with cardioembolic infarctions would develop a 
second embolism within the first 2 weeks of the onset of 
symptoms [11]. In our experience, embolism recurrence 
during hospitalization occurred in 24 of 324 patients with 
cardioembolic stroke consecutively attended over a 10-year 
period (6.9% of cases) [45]. Embolic recurrence occurred 
within the first 7 days of neurological deficit in 12 patients 
(50%). The mean time of recurrence after stroke onset was 
12 days. Recurrence of embolism within the first 30 days 
was observed in 5 of the 81 patients (6.1%) in the study of 
Yamanouchi  et al. [46] in patients with cardioembolic 
infarction and non-valvular atrial fibrillation, in 6% of 
cerebral infarcts in the study of Sacco et al. [47], in 3.3% of 
patients from the Stroke Data Bank [43], and in 4.4% of 
patients included in the Lausanne Stroke Registry [48]. 
  In our study, embolism recurrence was multiple in 3 
cases (12.5%), which is consistent with data in the study of 
Yamanouchi et al. [46] in which 7 of 21 patients with cardio-
embolic infarctions had two or more stroke recurrences. The 
maximal risk of recurrence was the immediate period after 
the cardioembolic stroke. 
  Mortality in patients with recurrent embolism was two-
fold higher as compared with the remaining patients (70.8% 
vs 24.4%) [45], in agreement with the study of Sacco et al. 
[47] (19% vs 8%) in cerebral infarctions in general. 
  It is important to know factors associated with early 
embolic recurrence in cardioembolic infarction because 
patients in which these risk factors are present constitute a 
subgroup with the highest risk severity, requiring early 
treatment and strict medical control. However, risk factors 
for stroke recurrence are less known than risk factors for 
first-ever stroke. In our experience, alcohol abuse (OR = 
21.8), hypertension with valvular heart disease and atrial 
fibrillation (OR = 4.3), nausea and vomiting (OR = 3.7), and 
previous cerebral infarct (OR = 3.2) were clinical predictors 
of cardioembolic stroke recurrence. In addition to these four 
variables, cardiac events (tachyarrhythmia, heart failure or 
acute myocardial infarction that occurred as medical 
complication during the patient’s hospital stay) were selected 
in the logistic regression model based on clinical, neuro-
imaging, and outcome variables (OR = 4.25).  
  The association of hypertension with valvular heart 
disease and atrial fibrillation was a predictive variable of 
stroke recurrence but none of these variables was statistically 
significant when they were independently analyzed. In 
another study, valvular heart disease associated with conges-
tive heart failure was the only predictive factor of stroke 
recurrence [49]. Although the presence of a structural cardiac 
disorder in a well known risk factor for system embolization 
[50,51], Lai et al. [52] also showed that patients with 
hypertension associated with non-valvular atrial fibrillation 
had a higher risk of embolic recurrence as compared to 
patients with only hypertension or with non-valvular atrial 
fibrillation only. 
  Involvement of cardiac center in the medulla oblongata 
may predispose to arrhythmias and cardiac arrest during the 
acute phase of stroke. Therefore, the presence of nausea and 
vomiting is a symptom usually associated with an infarction 
in the vertebrobasilar territory or progression compression of 
the brainstem due to an infarction in the carotid territory with 
transtentorial herniation, a clinical condition that can cause 
heart rhythm disturbances by concomitant involvement of 
the cardiac center and predispose to a potential cardioem-
bolic recurrence [53-56]. 
  In contrast to data observed in our study, the presence of 
a previous cerebral infarction was not a predictor of 
recurrence in the study of Sacco et al. [47]. However, other 
authors consider the presence of a cerebral infarction is one 
of the most powerful predictive factors recurrent embolism 
[54-58]. In the study of van Latum et al. [59], a previous 
thromboembolism of any kind was also a significant predic-
tor of stroke recurrence. 
  Alcohol abuse was an important predictor of recurrent 
embolism in our experience of cardioembolic infarction [45], 
which is similar to that observed in the study of Sacco et al. 
[47]. There is evidence of a strong relationship between 
stroke and alcohol: a) alcohol intoxication is a risk factor for 
cerebral infarction [60]; b) a higher frequency of alcohol 
abuse among stroke patients has been demonstrated [61-63]; 
c) other studies even claim that continued alcohol abuse is a 
true risk factor for stroke [64-67]. In Caucasian populations, 
"J-shaped" relationship has been documented between the 
protective effect of mild daily alcohol consumption and an 
increase in the risk of cerebral infarction by increasing daily 
alcohol consumption [61-63]. Although its effect on cardio-
embolic stroke is still unclear, there are several patho-
physiological mechanisms by which alcohol can cause stroke 
[61,68-79]. These include the following:  
a)  favoring hypertension, increasing platelet aggregation, 
plasma osmolarity, hematocrit, and erythrocyte aggre-
gation and deformability;  
b)  a consequence of a dilated cardiomyopathy due to 
alcohol abuse;  
c)  induction of cardiac arrhythmias (atrial fibrillation, 
ventricular extrasystoles, junctional tachycardia, 
paroxysmal supraventricular tachycardia, and ventric-
ular tachycardia in subjects who are habitual alcohol 
consumers, in sporadic alcohol users, and in those 
abstaining from alcohol [72]. Ethanol also increases 
adrenal release of catecholamines, which predisposes to 
arrhythmogenicity; in addition, acetaldehyde –a major 
alcohol metabolite- is also arryhthmogenic [73,64]. 
d)  changes in the cerebral blood flow and autoregulation in 
relation to alcohol abuse have been also reported; 
e)  liver disease secondary to alcohol abuse [68]. 
  Our study therefore suggest that alcohol abuse is an 
important independent factor associated with embolic recur-
rence in cardioembolic stroke 
  Any of the mechanisms outlined above may predispose 
to a new embolism, although the presence of a non-ischemic 
cardiomyopathy associated with the possibility of cardiac 
arrhythmia are probably the more common potential 
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  A classification system based on independent risk factors 
for stroke and used in clinical practice for predicting stroke 
in patients with non-valvular atrial fibrillation is the 
CHADS2 index [80]
 (acronym for Congestive heart failure, 
Hypertension, Age, Diabetes mellitus and stroke). CHADS2 
is formed by assigning 1 point each for the presence of 
congestive heart failure, hypertension, age 75 years or older, 
and diabetes mellitus, and by assigning 2 points for history 
of stroke or transient ischemic attack. Those patients with 
CHADS2 score of 0 or 1 have a low annual risk of stroke 
(1%), CHADS2 score of 2 identifies patients with moderate 
risk (annual risk of 2.5%), and patients with a score of 3 or 
greater are estimated to have a high risk of stroke (annual 
risk > 5%).  
  Early embolism is the main independent risk factor for 
in-hospital mortality in patients with cardioembolic infarc-
tion [40].Timing of initiation of anticoagulant treatment 
remains an area of uncertainty, since there is concern 
regarding exacerbating the risk of hemorrhage into regions 
of infarction (”hemorrhagic transformation”) after ischemic 
stroke. Guidelines propose arbitrary deferral of anticoagu-
lation for 2 weeks in patients hospitalized with stroke by 
extrapolation from acute trials with full-dose heparin, where 
reduced early recurrent ischemic stroke is balanced by 
increased hemorrhagic risk. In patients with transient ische-
mic attack or minor stroke and with exclusion of cerebral 
hemorrhage, oral anticoagulation can be initiated within 3-5 
days. However, we agree with Chamorro et al. [8] that 
secondary prevention with anticoagulants should be started 
immediately if possible in high recurrent embolic cardioem-
bolic stroke risk patients without contraindications, such as 
falls, poor compliance, uncontrolled epilepsy, or gastroin-
testinal bleeding. Thus, contrary to the recommendation to 
delay anticoagulation in patients with extensive cardioem-
bolic infarction or marked neurological deficit, immediate 
anticoagulation may be indicated in this subpopulation of 
cardioembolic infarction with maximal risk for early 
cardioembolic recurrence. According to Yasaka et al. [44], 
early anticoagulation with intravenous sodium heparin 
reduces the frequency of recurrent events and would reduce 
mortality, providing that it is initiated as soon as possible 
and maintaining activated thromboplastin time values below 
twice the control values. Oral anticoagulation with warfarin 
would be indicated later. 
EARLY DIFFERENTIAL DIAGNOSIS BETWEEN 
CARDIOEMBOLIC AND ATHEROTHROMBOTIC 
INFARCTS  
  Clinical data exclusive for cardioembolic infarctions or 
atherothrombotic infarctions are lacking. However, to 
establish an early diagnosis of cardioembolic infarction may 
have a therapeutic interest. In a study of our group [81], it 
was shown that atrial fibrillation and sudden onset of neuro-
logical symptoms were independent clinical factors 
significantly associated with cardioembolic stroke, whereas 
hypertension, chronic obstructive pulmonary disease, diabe-
tes, dyslipemia, and age were clinical variables indepen-
dently associated with atherothrombotic infarction. 
  On the other hand, clinical data traditionally related to 
cardioembolic infarction, such as seizures or headache, were 
not predictors of cardioembolic stroke, which is consistent 
with results of the studies of Ramirez-Lassepas et al. [82], 
Kittner et al. [83,84], and Caplan et al. [20]. 
ATRIAL FIBRILLATION IN CARDIOEMBOLIC AND 
ATHEROTHROMBOTIC INFARCTIONS  
Atrial fibrillation is the main cardiac disorder in the different 
series of cardioembolic infarctions from industrialized 
countries reported in the literature [27,37,85]. However, 
atrial fibrillation can be also observed in atherothrombotic 
infarcts, not as an embolic etiology but a marker of other 
conditions that lead to ischemic stroke, such as athero-
sclerosis. It may be therefore considered as an epipheno-
menon or a clinical manifestation of atherosclerotic disease 
[50]. In this respect, not all cerebral infarctions in patients 
with atrial fibrillation are of cardioembolic origin [21]. In 
our study, atrial fibrillation was diagnosed in 16.5% of 
patients with thrombotic occlusion or arterial stenosis grater 
than 70% presumably responsible for the cerebral infarction 
[86]. In these cases, some clinical or echocardiographic 
findings related to cardioembolism, such as recent conges-
tive heart failure or increase of the left atrial size, or left 
ventricular dysfunction were absent [87,88]. Bogousslavsky 
et al. [21] showed that 76% of patients with cerebral infarcts 
in the carotid vascular territory with atrial fibrillation, the 
presumable pathophysiological mechanism of stroke was 
cardioembolic since a significant arterial vascular disease 
could not be documented. However, in 11% of the cases, the 
presumable mechanism was atherosclerosis because severe 
arterial stenosis or occlusion correlated with clinical features, 
and in the remaining 13%, the cerebral infarct could be 
explained by occlusion of small perforating arterial vessels 
in association with hypertension. 
  Accordingly, in a patient with cerebral infarction and 
atrial fibrillation it is important to make an early and precise 
diagnosis of the subtype of cerebral infarct, although the 
differential diagnosis between cardioembolic and athero-
thrombotic stroke with atrial fibrillation may be difficult to 
establish at the onset of neurological deficit. In recent 
classifications of stroke subtypes, this distinction is not made 
and these patients are included in the subgroup of cerebral 
infarctions of undetermined cause due to the simultaneous 
presence of two potential etiologies [89]. However, it should 
be noted that using the results of appropriate neurological 
and cardiological studies carried out in a delayed during 
hospitalization, in most of the cases, it is possible to establish 
the correct classification of stroke in the definite nosological 
entity [20]. 
  In our experience based on 2000 patients with acute 
cerebrovascular disease [86], 1712 (85.6%) had a cerebral 
infarction. A total of 347 (17.4%) were classified as cardio-
embolic infarction, 452 (22.6%) as atherothrombotic infarc-
tion. Patients with cardioembolic infarction and atrial fibril-
lation accounted for 76.6% of the cases (n = 226), and 
patients with atherothrombotic infarction and atrial fibril-
lation for 16.5% (n = 75). 
Cardioembolic Infarctions with and without Atrial 
Fibrillation 
  When patients with cardioembolic infarction with and 
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of heart failure, sudden onset of neurological deficit, altered 
consciousness, motor, sensory and visual deficits, and parie-
tal topography of the ischemic lesion were more frequently 
recorded in cardioembolic stroke patients with atrial fibril-
lation. Coronary heart disease, smoking, and topography of 
the infarct in the internal capsule were more frequent in 
cardioembolic stroke patients without atrial fibrillation. The 
in-hospital mortality rate was 31.6% in patients with atrial 
fibrillation and 14.8% in those without atrial fibrillation (P < 
0.01) [86]. 
Atherothrombotic Infarctions with and without Atrial 
Fibrillation 
  In the comparison of patients with atherothrombotic 
infarction with and without atrial fibrillation, those with 
atrial fibrillation were older, with a predominance of 
females, and a higher frequency of coronary and valvular 
heart disease, sudden onset of neurological deficit, sensory 
and visual deficits, speech disturbance, parietal, temporal, 
and occipital topography, and infarction in the vascular 
territory of the middle cerebral artery. Cardiac events were 
also more frequent. In atherothrombotic infarcts without 
atrial fibrillation, smoking, involvement of the cranial nerves 
and vertebral vascular topography were more common. 
Absence of functional dysfunction on hospital discharge was 
also more frequent. The in-hospital mortality rate was 29.3% 
in patients with atrial fibrillation and 18.8% in those without 
atrial fibrillation (P < 0.04) [86]. 
Cardioembolic Infarctions and Atherothrombotic 
Infarctions with Atrial Fibrillation 
  When predictors of cardioembolic infarction or athero-
thrombotic infarction with atrial fibrillation were assessed in 
the multivariate analysis, rheumatic valve disease (OR = 4.6) 
and sudden onset of symptoms (OR = 1.8) were inde-
pendently associated with cardioembolic stroke, whereas 
subacute stroke onset (OR = 8.01), chronic obstructive 
pulmonary disease (OR = 5.2), hypertension (OR = 3.6), 
dyslipemia (OR = 2.6), and diabetes (OR = 2.26) were 
independently associated with atherothrombotic infarction 
[86]. 
  It should be noted that atrial fibrillation had a negative 
effect on outcome, both in cardioembolic and athero-
thrombotic infarction. It has been hypothesized that the 
worse outcome associated with atrial fibrillation may be 
explained by a higher prevalence of heart failure and 
ischemic heart disease. This hypothesis coincides in part 
with our results, given that a higher occurrence of heart 
failure in patients with cardioembolic stroke and a higher 
frequency of ischemic heart disease in patients with 
atherothrombotic stroke were observed. This may contribute 
to a decrease in cerebral blood flow as cerebral auto-
regulatory mechanisms in the ischemic area are impaired 
[90]. Other authors suggest that chronic atrial fibrillation 
may cause a significant reduction of regional blood flow 
[91], which may normalize when sinus rhythm is attained 
after successful cardioversion [92]. Other studies indicate 
that an increase in mortality may be explained by the more 
advanced age of the patients, a higher volume of the lesion, 
or a higher initial intensity of focal neurological deficit in 
patients with atrial fibrillation [93,94]. In summary, cerebro-
vascular disease in ischemic cardioembolic or atherothrom-
botic infarct is more severe in the presence of atrial fibrilla-
tion as compared to patients with normal sinus rhythm. 
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